The Global Market for Chiral Technology Enabling Products is Projected to Reach US$7.6 Billion by 2022

Supportive Regulations, Government Investments, & Patent Extensions Drive the Global Chiral Technology Market, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Chiral Technology market. The global market for Chiral Technology Enabling Products is projected to reach US$7.6 billion by 2022, driven by government investments and incentives, supportive regulations, and extension of patent protection for chiral extensions of existing non-chiral drugs.

Chiral technology and chirality are widespread in the lives of people. Hair sprays, clothes, drugs for treating diseases, and several common materials are all composed of organic molecules, many of them chiral. Over the past few years, progress made in the technology has had a growing influence on pharmaceutical research and development. Chiral technology also plays a pivotal role in addressing requirements of the pharmaceuticals sector in the manufacture of optically pure molecules, including APIs (Active Pharmaceutical Ingredients) and intermediates that are utilized as the framework for single enantiomer drugs. Robust growth in the market is driven by supportive regulations, government investments and incentives, and continuous expansion of pharmaceutical and biotechnology industries. Apart from regulations, drug efficiency and cost efficiency, the major and important factor driving growth of chiral intermediates in pharmaceuticals is the extension of patent protection for drugs manufactured from enantiomers. Chiral extensions of existing non-chiral drugs utilize a new compound that differs in many ways from the older compound and automatically leads to an extension of the all-important patent rights.

Technological advancements and collaborations between academic institutions and research labs are driving demand for chiral technologies, together with research activities in the fields of medicines, genomics, proteomics, and metabolomics which are helping increase the use of chiral columns. New developments in the field of chiral technology as well as demand for enantiopure compounds are expected to spur growth in the market. Future growth in the market will be supported by increasing spending by several governments on clinical research, strong focus of companies on acquisitions and mergers to expand product portfolios and market presence and growing availability of next-generation chiral chromatography methods with sophisticated features. Despite the opportunities for growth, the market will face challenges coming from the complexity of chiral chemistry, slow commercialization of novel chiral technology-based chemicals and drugs, lack of proficient skilled staff and high cost of chromatography equipment.

As stated by the new market research report on Chiral Technology, Europe represents the largest market worldwide. Asia-Pacific, Latin America and the Middle East together rank as the fastest growing market with a combined CAGR of 7.1% over the analysis period, led by increased outsourcing of drug development activities to China and India. China represents the largest as well as the fastest growing market for chiral technology. While increasing R&D activities and growing adoption in the pharmaceutical and biotechnology industries are the primary drivers of chiral chromatography columns in India, strong focus on research remains the most important factor for increasing penetration of chiral chromatography columns in Japan. Chiral Intermediates constitute the largest segment in the global chiral technology enabling products market, while Pharmaceuticals represent the largest end-use application area for chiral technology enabled products.

Major players covered in the report include Agilent Technologies Inc., Albemarle Corporation, BASF SE, Cambrex Corporation, Chiral Quest (Suzhou) Co. Ltd., Daicel Corporation, Chiral Technologies Inc., Johnson Matthey PLC, Phenomenex Inc., Regis Technologies Inc., Shasun Pharmaceuticals Limited, Shimadzu Corporation, Sigma Aldrich Corp., Solvias AG, Thermo Fisher Scientific Inc., and YMC America Inc., among others.

The research report titled "Chiral Technology: A Global Strategic Business Report" announced by Global Industry Analysts Inc., provides a comprehensive review of trends, issues, and strategic industry activities of major companies worldwide. The report provides market estimates and projections for geographic markets, such as the United States, Japan, Europe, and Rest of World. The report also analyzes the Chiral Technology Enabling Products market by segments - Intermediates, Analytical, and Others. End-use applications analyzed in the report include Pharmaceuticals, and Agrochemicals.

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.